The US Food and Drug Administration FDA has approved Symbravo, an oral combination of meloxicam and rizatriptan, for the treatment of acute migraine with or without aura in adults, ...

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

ValiRx announced on Wednesday that it has entered into an evaluation and option agreement with Canada-based Altus Formulation ...

This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine Research Centre.

Researchers designed oligopeptides that could co-assemble with therapeutic cargoes to create nanoparticles that improved the ...

A team of scientists has created a ground-breaking method for improving drug formulations by employing specifically ...

This study reveals efficient synthesis of ibuprofen:nicotinamide co-crystals via mechanochemistry, highlighting ...

Zerion Pharma & Aché collaborate to exploit the Dispersome technology for improvement of two marketed drug products: Copenhagen, Denmark Saturday, January 25, 2025, 16:00 Hrs [IS ...

A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.